188 related articles for article (PubMed ID: 25980696)
1. Low expression of B-cell-associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis.
Tan N; Liu Q; Liu X; Gong Z; Zeng Y; Pan G; Xu Q; He S
Histopathology; 2016 Jan; 68(2):221-9. PubMed ID: 25980696
[TBL] [Abstract][Full Text] [Related]
2. Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patients.
Hang X; Wu Z; Chu K; Yu G; Peng H; Xin H; Miao X; Wang J; Xu W
Tumour Biol; 2016 Nov; 37(11):15079-15085. PubMed ID: 27658779
[TBL] [Abstract][Full Text] [Related]
3. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.
Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software.
Pan C; Wang X; Chen W; Tao C; Xu X; Jin L; Chen Y; Zhu L; Zhou L; Pan Z
Med Oncol; 2015 Jan; 32(1):359. PubMed ID: 25432695
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
[TBL] [Abstract][Full Text] [Related]
6. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
7. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
9. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
14. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
[TBL] [Abstract][Full Text] [Related]
15. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
16. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
[TBL] [Abstract][Full Text] [Related]
17. Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma.
Zhang JB; Zhang B; Guo L; Lin ZH; Li XQ; Guo K; Sun HC; Ye QH
Oncotarget; 2015 Nov; 6(37):40223-34. PubMed ID: 26474280
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma.
Ye K; Wang Z; Zhang G; Liang S
J Invest Surg; 2010 Jun; 23(3):163-9. PubMed ID: 20590388
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of caprin1 expression is associated with poor prognosis in hepatocellular carcinoma.
Tan N; Dai L; Liu X; Pan G; Chen H; Huang J; Xu Q
Pathol Res Pract; 2017 Dec; 213(12):1563-1567. PubMed ID: 29037839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]